ORBIMED ADVISORS LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$4.2T
Holdings
107
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (107 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | TNGXTANGO THERAPEUTICS INC | 550,000 | $753.5M | 0.02% | |
| 102 | IVVDINVIVYD INC | 933,500 | $565.0M | 0.01% | |
| 103 | KRROKORRO BIO INC | 32,400 | $564.1M | 0.01% | |
| 104 | NXTCNEXTCURE INC | 1,141,200 | $548.1M | 0.01% | |
| 105 | ANROALTO NEUROSCIENCE INC | 250,000 | $540.0M | 0.01% | |
| 106 | —DIH HLDG US INC | 1,915,000 | $442.9M | 0.01% | |
| 107 | XERSXERIS BIOPHARMA HOLDINGS INC | 80,420 | $441.5M | 0.01% | |
| 108 | —LAKESHORE BIOPHARMA CO LTD | 140,428 | $344.0M | 0.01% |
PreviousPage 2 of 2